A new study conducted by the team of scientists from the Wellcome Trust Sanger Institute and their national collaborators aims to extract genome sequences to fight malaria that still cause 10 million cases each year.
A new malaria vaccine which has shown efficient results and proved to be safe has been tested on humans and mice. The vaccine uses a weakend version of P. falciparum.
The all new strategy, to test the new vaccine is to get bitten by mosquitos.
Researchers undergo first phase trials on mice and humans using a weakened variant of malarial parasite, which doesn't cause malaria infection rather, it formed antibodies.
Danish researchers have accidentally discovered that an experimental malaria vaccine can kill off cancer tumors.
The European Medicines Agency green lights the world's first Malaria vaccine. WHO to review the vaccine next.
